Weight management · 12 min read
The 2026 GLP-1 guide: what works, what costs less.
A plain-English walkthrough of every FDA-approved GLP-1 medication — dosing, side effects, real cost, and how to pick one with your clinician.
Medically reviewed by Jane Novak, MD, MPHUpdated May 15, 2026
Read articleJane Novak, MD, MPH
MD, MPH · Endocrinology · Internal Medicine
View profile →
Marisa Chen, RD
RD · Registered Dietitian · 12 years GLP-1 clinic experience
View profile →
Priya Sharma, NP
NP · Nurse Practitioner · GLP-1 specialty clinic
View profile →
Editorial-independent. No provider can pay for higher ranking. See our methodology.
30-second match finder
Not sure which GLP-1 provider fits your situation?
Four short questions on coverage, route, speed, and what matters most — we map you to one of four buyer profiles and surface the editorial pick. Affiliate links disclosed at the result.
- Cash-payCheapest sustainable monthly cost
- With insurancePA support + appeals filing
- No needlesWidest oral GLP-1 formulary
- Fast startSame-week first dose
The best of health and wellness
Get our weekly newsletter
Reviewer-vetted GLP-1 updates, shortages, and savings — 5 min/week, no filler.
Explore by health topic
View allExplore GLP-1 guides
Check an interaction
Is it safe to combine something with your GLP-1?
Am I eligible?
Which GLP-1 fits your condition, and how to qualify.
Track the market
Live supply status and what is coming next.
Trending this week
What's moving in the GLP-1 space
- #1+34%
Foundayoorforglipron
Daily oral GLP-1 launched at LillyDirect — first non-injectable in the class.
- #2+18%
Zepboundtirzepatide
Only GLP-1 FDA-approved for obstructive sleep apnea (Dec 2024).
- #3+12%
Wegovysemaglutide 2.4 mg
Hims rolled out a $149/mo oral starter — cheapest brand-name path.
- #4no change
Mounjarotirzepatide
T2D-only label; Zepbound is the OW variant. Prescription share stable.
- #5-9%
Ozempicsemaglutide
Off-label weight-loss searches declining as Wegovy and Zepbound take share.
Refreshed weekly from Google Trends search volume, FDA orange-book prescription-share data, and editor-tracked drug-shortage updates. Last refresh: May 24, 2026.
Health News
All newsGIP/GLP-1 dual receptor agonistNEW
Mounjaro: 2026 dosing and side-effect update
GLP-1 receptor agonist (daily injection)NEW
Saxenda: 2026 dosing and side-effect update
GLP-1 receptor agonist (oral tablet)
Rybelsus: 2026 dosing and side-effect update
Condition
Type 2 diabetes: what new GLP-1 evidence means for treatment
Condition
Obesity: what new GLP-1 evidence means for treatment
Condition
Obstructive sleep apnea: what new GLP-1 evidence means for treatment
Medically reviewed
Meet our editorial team
Every clinical page is reviewed by a licensed clinician with relevant specialty expertise — endocrinology, primary care, pharmacology, or bariatric medicine.
5+ medical reviewers · 60+ years combined experience
People also ask
Common questions about GLP-1 medications
- Which GLP-1 medication produces the most weight loss?
- Tirzepatide 15 mg (Zepbound) leads the class with ~22.5% mean body-weight reduction at 72 weeks in the SURMOUNT-1 trial. Semaglutide 2.4 mg (Wegovy) averages ~14.9% at 68 weeks (STEP-1). Individual response varies — about 1 in 3 trial participants reached ≥20%; about 1 in 6 lost less than 5%.
- How much does a GLP-1 cost without insurance in 2026?
- Brand-name list prices run ~$800-1,350/mo. Manufacturer savings cards (NovoCare Wegovy, Zepbound Savings Card) cap commercial-insurance copays at $25-225/mo. Eli Lilly Direct sells Zepbound vials direct-to-patient at $349-499/mo cash. Compounded semaglutide from licensed 503A pharmacies starts ~$149/mo.
- Is Ozempic FDA-approved for weight loss?
- No. Ozempic is FDA-approved for type 2 diabetes management and cardiovascular risk reduction in adults with T2D. Wegovy is the same molecule (semaglutide) FDA-approved for chronic weight management. Off-label Ozempic prescribing for weight loss is common but technically off-label.
- What happens if you stop taking a GLP-1?
- Trial extension data (STEP-1 follow-up, SURMOUNT-4 withdrawal) show roughly two-thirds of lost weight is regained within 12 months of stopping. GLP-1 therapy for weight management is FDA-labeled for chronic use.
- Is compounded semaglutide safe and legal in 2026?
- Compounded semaglutide is legal when prescribed by a licensed clinician and dispensed by a licensed 503A pharmacy on a patient-specific basis. Mass identical-copy compounding ended when the FDA cleared the shortage in February 2025. Verify PCAB accreditation and US pharmacy licensure.
- Which insurance plans cover GLP-1 for weight loss?
- Most commercial carriers (Aetna, Anthem, Cigna, UnitedHealthcare, Humana, BCBS Federal) cover Wegovy and Zepbound with prior authorization documenting BMI ≥30 (or ≥27 + a weight-related comorbidity). Medicare Part D excludes anti-obesity drugs by federal law; diabetes use is broadly covered.
Healthline tools
Prior Auth Letter
Generate a doctor-ready PA appeal letter in 2 minutes.
Drug Interactions
Screen GLP-1 against your current medication list.
Pill Identifier
Identify an unknown tablet or capsule.
GLP-1 medications: A to Z
Learn everything you need to know about specific GLP-1 prescriptions — dosing, side effects, real cost, and access.
Browse medications →